Stockscreener 앱 받기
61.37
0.87%
-0.61
시간 외 거래:
61.37
전일 마감가:
$61.98
열려 있는:
$61.42
하루 거래량:
1.88M
Relative Volume:
0.73
시가총액:
$11.73B
수익:
$217.77M
순이익/손실:
$-438.86M
주가수익비율:
-25.46
EPS:
-2.41
순현금흐름:
$-456.33M
1주 성능:
-4.74%
1개월 성능:
+16.23%
6개월 성능:
+59.29%
1년 성능:
+143.81%
1일 변동 폭
$60.22
$61.91
1주일 범위
$60.22
$69.48
52주 변동 폭
$21.72
$69.48
Bridgebio Pharma Inc Stock (BBIO) Company Profile
명칭
Bridgebio Pharma Inc
전화
(650) 391-9740
주소
3160 PORTER DR., PALO ALTO, CA
BBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBIO
Bridgebio Pharma Inc
|
61.37 | 11.94B | 217.77M | -438.86M | -456.33M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bridgebio Pharma Inc Stock (BBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | Raymond James | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-14 | 개시 | Jefferies | Buy |
| 2025-07-09 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-17 | 개시 | Wolfe Research | Outperform |
| 2025-03-31 | 개시 | Redburn Atlantic | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-10-03 | 개시 | Oppenheimer | Perform |
| 2024-09-04 | 개시 | Piper Sandler | Overweight |
| 2024-03-21 | 재개 | Raymond James | Outperform |
| 2024-01-31 | 개시 | BMO Capital Markets | Market Perform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-07 | 개시 | Citigroup | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-07-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-04-19 | 개시 | Evercore ISI | Outperform |
| 2023-02-06 | 개시 | Cowen | Outperform |
| 2021-12-27 | 재확인 | Mizuho | Buy |
| 2021-12-27 | 재확인 | SVB Leerink | Outperform |
| 2021-09-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-05-21 | 개시 | UBS | Buy |
| 2021-03-22 | 재확인 | Goldman | Buy |
| 2021-02-22 | 재개 | JP Morgan | Overweight |
| 2021-02-09 | 재개 | Goldman | Buy |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-10 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-25 | 개시 | BofA/Merrill | Neutral |
| 2020-05-19 | 개시 | BTIG Research | Buy |
| 2020-04-13 | 개시 | H.C. Wainwright | Buy |
| 2020-02-19 | 개시 | Mizuho | Buy |
| 2019-07-26 | 개시 | Raymond James | Outperform |
| 2019-07-22 | 개시 | BMO Capital Markets | Outperform |
| 2019-07-22 | 개시 | Goldman | Buy |
| 2019-07-22 | 개시 | JP Morgan | Overweight |
| 2019-07-22 | 개시 | Jefferies | Buy |
| 2019-07-22 | 개시 | Piper Jaffray | Overweight |
| 2019-07-22 | 개시 | SVB Leerink | Outperform |
모두보기
Bridgebio Pharma Inc 주식(BBIO)의 최신 뉴스
BridgeBio Pharma (NASDAQ:BBIO) Given Buy Rating at HC Wainwright - MarketBeat
BridgeBio to Participate in November Investor Conferences - The Manila Times
BridgeBio (Nasdaq: BBIO) to Join UBS and Jefferies Conferences; Webcasts Nov 10 & 18 - Stock Titan
How BridgeBio Pharma Inc. stock performs in stagflationSwing Trade & Fast Gain Stock Tips - newser.com
Analyzing BridgeBio Pharma Inc. with risk reward ratio chartsWeekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Can machine learning forecast BridgeBio Pharma Inc. recoveryBuy Signal & Momentum Based Trading Signals - newser.com
What moving averages say about BridgeBio Pharma Inc.July 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace
Are Shares of BridgeBio Pharma Still a Bargain After 146% Rally and Clinical Trial Buzz? - Yahoo Finance
Mizuho Boosts Price Target on BridgeBio Pharma to $91 From $64, Keeps Outperform Rating - MarketScreener
Using Bollinger Bands to evaluate BridgeBio Pharma Inc.M&A Rumor & Real-Time Volume Trigger Notifications - newser.com
BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BB - GuruFocus
Real time alert setup for BridgeBio Pharma Inc. performance2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
BridgeBio Pharma to Present Ten Digital Posters on Acoramidis at AHA Scientific Sessions 2025 - Quiver Quantitative
BBIO: HC Wainwright & Co. Reiterates Buy Rating with $90 PT | BBIO Stock News - GuruFocus
BridgeBio (NASDAQ: BBIO) to share 10 AHA 2025 posters on acoramidis ATTRibute-CM data - Stock Titan
HC Wainwright & Co. Reiterates BridgeBio Pharma (BBIO) Buy Recommendation - Nasdaq
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q3 2025 Earnings Call Transcript - MSN
New York Life Investment Management LLC Makes New $548,000 Investment in BridgeBio Pharma, Inc. $BBIO - MarketBeat
Cantor Fitzgerald Issues Positive Estimate for BBIO Earnings - MarketBeat
What is Leerink Partnrs' Estimate for BBIO FY2025 Earnings? - MarketBeat
Nisa Investment Advisors LLC Sells 4,667 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
What indicators show strength in BridgeBio Pharma Inc.July 2025 Retail & Verified Momentum Stock Watchlist - newser.com
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
BridgeBio targets 30%+ market share for Attruby while advancing late-stage pipeline and reporting $120.7M Q3 revenue - MSN
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells $13,206,742.22 in Stock - MarketBeat
BridgeBio Pharma, Inc. (BBIO) Stock forecasts - Yahoo! Finance UK
BridgeBio Pharma, Inc. (BBIO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
BridgeBio Pharma, Inc. (BBIO) Stock Forecasts - Yahoo! Finance Canada
BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BridgeBio Pharma director sells $13.2m in BBIO stock By Investing.com - Investing.com Canada
Bridgebio Pharma Insider Sold Shares Worth $13,206,528, According to a Recent SEC Filing - MarketScreener
[Form 4] BridgeBio Pharma, Inc. Insider Trading Activity - Stock Titan
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $95.00 at TD Cowen - MarketBeat
BridgeBio Pharma, Inc. (BBIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
BridgeBio Pharma: Bullish On Attruby's Momentum And 2026 Catalysts (BBIO) - Seeking Alpha
BBIO: Goldman Sachs Raises Price Target and Maintains Buy Rating | BBIO Stock News - GuruFocus
Raymond James Financial Reaffirms "Outperform" Rating for BridgeBio Pharma (NASDAQ:BBIO) - MarketBeat
Piper Sandler Issues Positive Forecast for BridgeBio Pharma (NASDAQ:BBIO) Stock Price - MarketBeat
Cantor Fitzgerald Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $110.00 - MarketBeat
What is HC Wainwright's Estimate for BBIO FY2026 Earnings? - MarketBeat
Equities Analysts Offer Predictions for BBIO FY2026 Earnings - MarketBeat
BridgeBio Pharma (NASDAQ:BBIO) Given Buy Rating at Truist Financial - MarketBeat
Emerald Mutual Fund Advisers Trust Sells 78,609 Shares of BridgeBio Pharma, Inc. $BBIO - MarketBeat
Will BridgeBio Pharma Inc. stock pay special dividendsCPI Data & Risk Controlled Swing Trade Alerts - newser.com
Why retail investors favor BridgeBio Pharma Inc. stockTrade Volume Report & Low Risk High Reward Ideas - newser.com
Piper Sandler Maintains BridgeBio Pharma (BBIO) Overweight Recommendation - MSN
Raymond James Reiterates BridgeBio Pharma (BBIO) Outperform Recommendation - Nasdaq
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) Director Sells 1,641 Shares of Stock - MarketBeat
BBIO: TD Cowen Raises BridgeBio Pharma Target Price to $95 | BBIO Stock News - GuruFocus
BridgeBio Pharma (NASDAQ:BBIO) Releases Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Bridgebio Pharma Inc (BBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):